NL-OMON25839
Recruiting
Not Applicable
X chromosome inactivation in human embryos obatined after either IVF or IVF/ICSI
Academic hospital Maastricht, the Netherlands0 sites420 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- IVF, ICSI, X chromosome inactivation, X chromosoom inactivatie
- Sponsor
- Academic hospital Maastricht, the Netherlands
- Enrollment
- 420
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Human surplus embryos, not suitable for transfer or cryopreservation, originating from an IVF or ICSI treatment
- •2\. Informed consent from patients
Exclusion Criteria
- •1\. Abnormal fertilized embryos
- •2\. Presence of multinucleated blastomeres
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
X-Chromosome Inactivation Status and Premature Ovarian FailurePremature Ovarian FailureNCT00295087University of Pittsburgh13
Completed
Not Applicable
X-chromosome Inactivation, Epigenetics and the TranscriptomeTurner SyndromeKlinefelter SyndromeTriple X Syndrome47 XYY SyndromeAortic AneurysmNCT01678261University of Aarhus110
Suspended
Phase 1
Study of Amblyomin-X in Advanced Solid TumorAdvanced CancerNCT03120130União Química Farmacêutica Nacional S/A24
Completed
Not Applicable
Study on the Association Between SXCI and RM and the Possible Genetic MechanismInfertility FemaleRecurrent MiscarriageNCT02504281ShangHai Ji Ai Genetics & IVF Institute257
Completed
Not Applicable
Anti-Xa activity after a reduced therapeutic dose of nadroparin in patients with renal impairment using a dosage guideline of the Dutch Federation of NephrologyRenal impairment10038430coagulation10014523NL-OMON44475Medisch Centrum Leeuwarden194